BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 11032168)

  • 1. Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways.
    Yin XM
    Cell Res; 2000 Sep; 10(3):161-7. PubMed ID: 11032168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death receptor-induced apoptotic and necrotic cell death: differential role of caspases and mitochondria.
    Denecker G; Vercammen D; Steemans M; Vanden Berghe T; Brouckaert G; Van Loo G; Zhivotovsky B; Fiers W; Grooten J; Declercq W; Vandenabeele P
    Cell Death Differ; 2001 Aug; 8(8):829-40. PubMed ID: 11526436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
    Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
    Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis.
    Yin XM; Wang K; Gross A; Zhao Y; Zinkel S; Klocke B; Roth KA; Korsmeyer SJ
    Nature; 1999 Aug; 400(6747):886-91. PubMed ID: 10476969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes.
    Yin XM
    J Mol Med (Berl); 2000; 78(4):203-11. PubMed ID: 10933582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bid-dependent generation of oxygen radicals promotes death receptor activation-induced apoptosis in murine hepatocytes.
    Ding WX; Ni HM; DiFrancesca D; Stolz DB; Yin XM
    Hepatology; 2004 Aug; 40(2):403-13. PubMed ID: 15368445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
    Ozören N; El-Deiry WS
    Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
    Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
    Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
    Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
    Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
    Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
    J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide.
    Brumatti G; Yon M; Castro FA; Bueno-da-Silva AE; Jacysyn JF; Brunner T; Amarante-Mendes GP
    Exp Cell Res; 2008 Feb; 314(3):554-63. PubMed ID: 18078929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E; Bennett BL; Manning AM; Qian T; Lemasters JJ; Brenner DA
    Gastroenterology; 2001 Apr; 120(5):1251-62. PubMed ID: 11266388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ; Ng LT; Lin CC
    Eur J Pharmacol; 2005 Aug; 518(2-3):96-106. PubMed ID: 16054126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death receptors leave a caspase footprint that Smacs of XIAP.
    Bratton SB; Cohen GM
    Cell Death Differ; 2003 Jan; 10(1):4-6. PubMed ID: 12655287
    [No Abstract]   [Full Text] [Related]  

  • 16. Cadmium induces apoptotic cell death in WI 38 cells via caspase-dependent Bid cleavage and calpain-mediated mitochondrial Bax cleavage by Bcl-2-independent pathway.
    Oh SH; Lee BH; Lim SC
    Biochem Pharmacol; 2004 Nov; 68(9):1845-55. PubMed ID: 15450950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-XL disrupts death-inducing signal complex formation in plasma membrane induced by hypoxia/reoxygenation.
    Wang X; Zhang J; Kim HP; Wang Y; Choi AM; Ryter SW
    FASEB J; 2004 Dec; 18(15):1826-33. PubMed ID: 15576486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway.
    Liu B; Fan Z
    Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death.
    Gross A; Yin XM; Wang K; Wei MC; Jockel J; Milliman C; Erdjument-Bromage H; Tempst P; Korsmeyer SJ
    J Biol Chem; 1999 Jan; 274(2):1156-63. PubMed ID: 9873064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.